Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024
Compare Balance Sheet Results of Goldline Pharmac
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
8.71
9.66
-0.95
-9.83%
Share Warrants & Outstandings
Total Reserve
1.65
32.36
-30.71
-94.90%
Shareholder's Funds
10.35
42.02
-31.67
-75.37%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
5.38
0.00
5.38
0.00%
Secured Loans
1.02
0.00
1.02
0.00%
Unsecured Loans
4.37
0.00
4.37
0.00%
Deferred Tax Assets / Liabilities
0.09
1.20
-1.11
-92.50%
Other Long Term Liabilities
0.88
0.42
0.46
109.52%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
4.16
1.62
2.54
156.79%
Current Liabilities
Trade Payables
2.06
4.49
-2.43
-54.12%
Other Current Liabilities
1.87
2.21
-0.34
-15.38%
Short Term Borrowings
7.84
0.00
7.84
0.00%
Short Term Provisions
0.00
5.38
-5.38
-100.00%
Total Current Liabilities
11.77
12.09
-0.32
-2.65%
Total Liabilities
26.28
55.72
-29.44
-52.84%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
3.71
19.25
-15.54
-80.73%
Less: Accumulated Depreciation
0.82
10.76
-9.94
-92.38%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
2.89
8.49
-5.60
-65.96%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.04
11.22
-11.18
-99.64%
Long Term Loans & Advances
0.00
0.00
0.00
0.00%
Other Non Current Assets
0.00
0.05
-0.05
-100.00%
Total Non-Current Assets
2.93
29.42
-26.49
-90.04%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
6.78
14.15
-7.37
-52.08%
Sundry Debtors
10.69
4.76
5.93
124.58%
Cash and Bank
1.24
2.65
-1.41
-53.21%
Other Current Assets
0.52
0.22
0.30
136.36%
Short Term Loans and Advances
4.12
4.52
-0.40
-8.85%
Total Current Assets
23.35
26.30
-2.95
-11.22%
Net Current Assets (Including Current Investments)
11.58
14.21
-2.63
-18.51%
Total Current Assets Excluding Current Investments
23.35
26.30
-2.95
-11.22%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.28
55.72
-29.44
-52.84%
Contingent Liabilities
0.00
3.69
-3.69
-100.00%
Total Debt
8.84
0.00
8.84
0.00%
Book Value per share (adjusted)
12.39
34.63
-22.24
-64.22%
Annual - Borrowings
Borrowings 11.03 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -0.90% vs 2.77% in Mar 2024
Annual - Other Long Term Liabilities
Other Long Term Liabilities 0.88 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 11.39% vs 16.18% in Mar 2024
Annual - Fixed Assets
Fixed Assets 2.89 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -15.00% vs 36.00% in Mar 2024
Annual - Investments
Investments 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 33.33% vs -57.14% in Mar 2024
Annual - Current Assets
Current Assets 23.35 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.74% vs 15.93% in Mar 2024
